Immunovant, a clinical-stage biopharmaceutical company, has been making headlines with recent insider trading activities, SEC filings, and analyst opinions. This…
Read More »Top Stories
In a landmark deal that underscores the continuing consolidation in the energy sector, ConocoPhillips (NYSE: COP) has announced the acquisition…
Read More »
In recent weeks, AST SpaceMobile has captured the attention of investors and industry experts with a series of groundbreaking announcements.…
Read More »
Predictive Oncology (NASDAQ: POAI) has seen a significant surge in its stock price, driven by the announcement of positive results…
Read More »
Insmed (NASDAQ: INSM) has recently been in the spotlight following a significant surge in its stock price. This rise is…
Read More »
Expectations about the future path of Federal Reserve interest-rate policy have been on a roller coaster this year, and the…
Read More »
This Memorial Day, investors are looking to history for clues about the market’s future performance. Traditionally, the post-Memorial Day period…
Read More »
In a groundbreaking move, Donald J. Trump’s 2024 presidential campaign has announced it will accept cryptocurrency donations, marking the first…
Read More »
The recent approval by the U.S. Securities and Exchange Commission (SEC) of spot Ethereum (ETHUSD) exchange-traded funds (ETFs) marks a…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »